Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.4.0.3
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating expenses:    
Research and development $ 2,293,273 $ 1,723,312
General and administrative 2,649,093 760,759
Loss from operations (4,942,366) (2,484,071)
Other income (expense)    
Change in fair value of warrant liability, unit purchase option liability and investor rights obligation (47,104) (535,291)
Interest expense, net (150,543) (218,357)
Total other expenses (197,647) (753,648)
Net loss $ (5,140,013) $ (3,237,719)
Net loss per share of common stock, basic and diluted $ (0.59) $ (4.98)
Weighted average shares of Common Stock outstanding, basic and diluted 8,650,143 649,721